Evidence map›Paper›PMID 37760499›Full record

ArticleCancers2023

Assessment of STAT4 Variants and Risk of Hepatocellular Carcinoma in Latin Americans and Europeans.

Alan Ayoub, Chimaobi M Anugwom, Jhon Prieto, Domingo Balderramo, Javier Diaz Ferrer, Angelo Z Mattos, Marco Arrese, Enrique Carrera, Zwier M A Groothuismink, Jeffrey Oliveira and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. STAT4 gene polymorphisms in human diseases.Frontiers in immunology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 7 countries.

Alan AyoubFaculty of Medicine, University of Zagreb, 10000 Zagreb, Croatia.ORCID 0009-0009-9396-4960
Chimaobi M AnugwomDepartment of Medicine, Division of Gastroenterology, Division of Infectious Disease, University of Minnesota, Minneapolis, MN 55455, USA.
Jhon PrietoCentro de Enfermedades Hepaticas y Digestives, Bogota 110121, Colombia.
Domingo BalderramoDepartment of Gastroenterology, Hospital Privado Universitario de Córdoba, Instituto Universitario de Ciencias Biomédicas de Córdoba, Córdoba X5016, Argentina.
Javier Diaz FerrerDepartment of Gastroenterology, Universidad San Martin de Porres, Lima 15024, Peru.ORCID 0000-0001-9748-5005
Angelo Z MattosGraduate Program in Medicine: Hepatology, Federal University of Health Sciences of Porto Alegre, Porto Alegre 90050-170, Brazil.
Marco ArreseDepartment of Gastroenterology, Pontificia Universidad Católica de Chile, Santiago 3580000, Chile.
Enrique CarreraDepartment of Gastroenterology, Universidad San Francisco de Quito, Quito 170901, Ecuador.
Zwier M A GroothuisminkDepartment of Gastroenterology and Hepatology, Erasmus Medical Center, 3015 CE Rotterdam, The Netherlands.
Jeffrey OliveiraDepartment of Gastroenterology and Hepatology, Erasmus Medical Center, 3015 CE Rotterdam, The Netherlands.
Andre BoonstraDepartment of Gastroenterology and Hepatology, Erasmus Medical Center, 3015 CE Rotterdam, The Netherlands.ORCID 0000-0001-8607-1616
Jose D DebesDepartment of Medicine, Division of Gastroenterology, Division of Infectious Disease, University of Minnesota, Minneapolis, MN 55455, USA.
Erasmus MC · NLUniversity of Minnesota · USHospital Privado · ARPontificia Universidad Católica de Chile · CLUniversidad de San Martín de Porres · PEUniversidad San Francisco de Quito · ECUniversity of Zagreb · HR

Funding

Impact of Hepatitis C and HIV coinfection on biological aging and hepatocellular carcinoma riskR21TW012390 · FIC · UNIVERSITY OF MINNESOTA · PI DEBES, JOSE DANIEL · 2022 to 2023
$500k
FIC NIH HHS R21 TW012390
6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide. The

Indexed as

hepatocellular carcinomasingle nucleotide polymorphismSTAT4

Identifiers

PMID37760499
PMCPMC10527221
OpenAlexW4386724986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.